Quantcast

Latest disease Stories

2014-09-18 08:30:50

Center supports research focused on effects of aging, creates groundwork for drugs that can postpone disease and extend lifespan ANN ARBOR, Mich., Sept. 18, 2014 /PRNewswire-USNewswire/ -- A $3 million grant from The Glenn Foundation for Medical Research will allow the University of Michigan to establish a national center of excellence in biogerontology research. The Glenn Center for Aging Research at U-M will focus on exploiting and expanding the growing evidence that drugs can...

2014-09-18 08:29:26

-ATHENA to Shed Light on Rare, Life-Threatening Kidney Disease - LA JOLLA, Calif., Sept. 18, 2014 /PRNewswire/ -- Regulus Therapeutics Inc. (NASDAQ: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, announced today it has initiated its ATHENA natural history of disease study in patients with Alport syndrome, a life-threatening genetic kidney disease with no approved therapy. The ATHENA study is designed to...

2014-09-17 23:16:06

‘Alzheimer’s—What They Forget to Tell You’ is an inspiring true account of author Caron Leid taking care of her mother for 13 years ONTARIO, Canada (PRWEB) September 17, 2014 Although more and more people are being affected by Alzheimer’s disease, there is not enough information surrounding the true daily struggle of the disease. But one thing is for sure, this disease does not only rob a person of their memory, it takes their dignity and independence with it....

2014-09-17 23:11:56

The Diabetes Protocol is a new product designed by Dr. Kenneth Pullman that reveals to people a highly advanced solution for treating diabetes for life. A detailed review on the site Vinamy.com indicates if this product is worth buying. Seattle, Wa (PRWEB) September 17, 2014 Diabetes currently has no cure. According to an article published by the Telegraph in August 2014, scientists made several breakthroughs in search for a “definite” cure for diabetes, but still failed. The article...

2014-09-17 08:29:26

- Phase 2 Clinical Results Show Positive Trends in Slowing Advancement of Disease - PALO ALTO, Calif., Sept. 17, 2014 /PRNewswire/ -- Neuraltus Pharmaceuticals, Inc. announced today that promising efficacy results of the Company's Phase 2 clinical program of NP001 for the treatment of amyotrophic lateral sclerosis (ALS, or Lou Gehrig's disease) are being highlighted today in an oral presentation at the inaugural Summit of the ALS Research Group, being held in Bloomington,...

2014-09-17 08:28:34

WASHINGTON, Sept. 17, 2014 /PRNewswire-USNewswire/ -- Health promotion and disease prevention programs have become ubiquitous in workplaces across the country. However, to deliver on their promises to improve employee well-being, reduce avoidable costs and enhance organizational functioning, these programs must be well designed, based on good scientific evidence, effectively executed and properly evaluated. To recognize organizations for outstanding health promotion programs that...

2014-09-16 20:27:17

-- Survey Data Requested by FDA for the September 26 Patient-Focused Drug Development Meeting for Idiopathic Pulmonary Fibrosis CHICAGO, Sept. 16, 2014 /PRNewswire-USNewswire/ -- The Pulmonary Fibrosis Foundation (PFF) announced today that it has submitted survey data from more than 1,100 patients and families suffering from pulmonary fibrosis (PF) to the U.S. Food and Drug Administration (FDA) for the Patient-Focused Drug Development Meeting for Idiopathic Pulmonary Fibrosis on...

2014-09-16 08:29:21

INDIANAPOLIS, Sept. 16, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and AstraZeneca today announced an agreement to co-develop and commercialize AZD3293, an oral beta secretase cleaving enzyme (BACE) inhibitor currently in development as a potential treatment for Alzheimer's disease. The progression of Alzheimer's disease is characterized by the accumulation of amyloid plaque in the brain. BACE is an enzyme associated with the development of beta-amyloid. Inhibiting BACE...

genetic testing prostate cancer
2014-09-16 07:06:57

John Hopton for redOrbit.com - Your Universe Online A study of more than 87,000 individuals of European, African, Japanese and Latino ancestry has revealed 23 new genetic susceptibility locations indicating risk of prostate cancer, contributing to greater knowledge and hope for future prevention of the disease. The study, co-led by Keck School of Medicine, University of Southern California (USC), and scientists and researchers in the United Kingdom, is the largest of its kind and the...

2014-09-15 23:03:41

Complimentary Hayes, Inc. webinar reviews new management options and their effects on patient outcomes. Lansdale, PA (PRWEB) September 15, 2014 For the 3.2 million people in the United States infected with the hepatitis C virus, disease management can be costly and debilitating. But are the new agents recently approved by the Food and Drug Administration (FDA) a better way to manage the disease? Direct-Acting Antiviral Agents for Hepatitis C Virus Infection—What You Need to Know is a...


Latest disease Reference Libraries

Marfan's Syndrome
2013-07-19 15:22:33

Marfan's syndrome is a genetic disorder of the connective tissue that causes excessively tall stature and long extremities. It is carried by the gene FBN1, which encodes the connective protein fibrillin-1, and is a dominant trait. The human genetic makeup contains a pair of FBN1 genes, so because of its dominance, inheriting one affected FBN1 gene from either parent will result in Marfan's syndrome. It effects both males and females, and has no ethnic bias. It was named after Antoine Marfan,...

0_ce8c5b23d8785d6957f1484978ad758f
2011-04-28 18:03:11

Yersinia enterocolitica is a species of gram-negative coccobacillus-shaped bacterium, belonging to the family Enterobacteriaceae. Infection from Yersinia enterocolitica causes the zoonotic disease yersiniosis. Most infected animals recover from the disease and become asymptomatic carriers. Acute infections lead to mild self-limiting entero-colitis or terminal ileitis in humans. Symptoms include watery or bloody diarrhea and fever. After oral uptake it replicates in the terminal ileum and...

45_d6be6f801c571ef90f6e4b56412c5274
2011-04-15 15:38:47

Helicobacter pylori is a Gram-negative, microaerophilic bacterium that can inhabit various areas of the stomach, particularly the antrum. It causes low-level inflammation of the stomach lining and is linked to gastric ulcers and stomach cancer. Out of those infected, 80%, are asymptomatic. It was initially named Campyloacter pyloridis and then renamed C. pylori to correct the Latin grammar error. It was later placed in the genus, Helicobacter. Over 50% of the population has H. pylori in...

0_f89eed643ffe5dbac62f76350c8b01c9
2011-04-15 14:02:16

Clostridium perfringens (formerly known as C. welchii) is a Gram-positive, rod-shaped, anaerobic, spore-forming bacterium of the genus Clostridium. It is always present in nature and is a normal component of decaying vegetation, marine sediment, the intestinal tract of humans, other vertebrates, insects, and soil. It can be a human pathogen and also harmlessly ingested. Commonly it is encountered in infections as a component of the normal flora where it takes a minor role in the disease....

45_7835ab5b89858b7a8f29bafdbf447884
2011-03-04 17:45:07

Zucchini Yellow Mosaic Virus (ZYMV) is an aphid-borne potyvirus and is regarded as a major pathogen of cucurbits. It affects pumpkins, squashes, vegetable marrows, courgettes, melons, watermelons, cucumbers, gherkins, and various gourds especially zucchinis. The effects are severe leaf mosaic, yellowing and eventually the leaves show "shoestring" symptoms. Fruits can become stunted, twisted and deformed by raised protuberances, which make them unmarketable. Infection may be spread through...

More Articles (14 articles) »
Word of the Day
barghest
  • A goblin in English folklore, often appearing in the shape of a large dog and believed to portend imminent death or misfortune.
  • A ghost, wraith, hobgoblin, elf, or spirit.
The origin of 'barghest' is not known, but it may be from perhaps burh-ghest, town-ghost, or German Berg-geist (mountain spirit) or Bär-geist (bear-spirit).
Related